Next generation HLA-haploidentical HSCT

Keyphrases

• Graft-versus-host Disease (GvHD) 100%
• HLA-haploidentical HSCT 100%
• Transplantation 66%
• CD4+ 33%
• CD8+ 33%
• Disease-free Survival 33%
• Leukemia Patients 33%
• T Cells 33%
• Phase I Study 33%
• Engraftment 33%
• Murine Model 33%
• Regulatory T (Treg) Cells 33%
• Donor Type 33%
• Relapse Rate 33%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 33%
• Leukemia Relapse 33%
• Failure Cause 33%
• Treg 33%
• Adoptive Immunotherapy 33%
• Opportunistic Pathogens 33%
• Annualized Relapse Rate 33%
• FoxP3+ 33%
• High-risk Adults 33%
• Post-transplant Relapse 33%
• Immunosuppressive Potential 33%
• Chronic Graft-versus-host Disease (cGVHD) 33%
• Historical Control 33%
• High-risk Acute Lymphoblastic Leukemia 33%
• T Cell Dysfunction 33%
• Transplant Immunosuppression 33%
• Infection Probability 33%
• Haplo-transplantation 33%

Immunology and Microbiology

• T Cell 100%
• Regulatory T Cell 100%
• CD4 50%
• CD8 50%
• Disease Free Survival 50%
• Engraftment 50%
• Haplotype 50%
• Infectious Agent 50%
• Immunosuppressive Drug 50%
• Allogeneic Stem Cell Transplantation 50%
• Acute Graft Versus Host Disease 50%
• Adoptive Immunotherapy 50%
• Immunosuppression 50%